IP Library Granted Patent US 8,603,823
Granted Patent B2
US 8,603,823 · App. 12/612,154 · Granted Dec 10, 2013

Methods and compositions for producing vitamin K dependent proteins

Inventors: Darrel W. Stafford (Carrborro, NC); Tao Li (San Diego, CA)
Assignee: The University of North Carolina at Chapel Hill
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,603,823
App. No.
12/612,154
Granted
Dec 10, 2013
Kind
B2
Abstract

The present invention relates to methods and compositions for improving the productivity of recombinant vitamin K dependent protein expression in host cells.

Claims (51)

1. An isolated host cell comprising a recombinant nucleic acid coding for a functional vitamin K epoxide reductase (VKOR), wherein the recombinant nucleic acid coding for the VKOR comprises a nucleotide sequence selected from the group consisting of:

1) a nucleotide sequence that encodes an amino acid sequence having at least 80% identity with the amino acid sequence of SEQ ID NO:10 and that encodes a VKOR;

2) a nucleotide sequence that that encodes a human VKOR;

3) a nucleotide sequence that encodes a mouse VKOR;

4) a nucleotide sequence that encodes a rat VKOR;

5) a nucleotide sequence that encodes a zebrafish VKOR;

6) a nucleotide sequence that encodes a Xenopus VKOR; and

7) a nucleotide sequence that encodes an Anopheles VKOR,

and a recombinant nucleic acid coding for a vitamin K dependent protein, wherein both the recombinant VKOR and the recombinant Vitamin K dependent protein are expressed in said host cell.

2. The host cell of claim 1 , wherein either the nucleic acid coding for recombinant VKOR or the nucleic acid coding for the recombinant Vitamin K dependent protein or both are expressed via an expression mode selected from the group consisting of one or more of the following: induced, transient, and permanent expression.

3. The host cell of claim 1 , wherein the host cell is a mammalian cell.

4. The host cell of claim 3 , wherein the mammalian cell is a cell derived from a mammalian cell line selected from the group consisting of one or more of the following: CHO cells and HEK293 cells.

5. The host cell of claim 1 , wherein the recombinant vitamin K dependent protein comprises a coagulation factor.

6. The host cell of claim 1 , wherein the coagulation factor is selected from the group consisting of one or more of the following: factor II, factor VII, factor VIIA, factor IX, factor X, prothrombin, Protein C, activated Protein C and Protein S.

7. The host cell of claim 6 , wherein the coagulation factor comprises human factor IX.

8. The host cell of claim 6 , wherein the coagulation factor comprises human factor VII.

9. A cell culture system comprising isolated cells that contain a recombinant nucleic acid coding for a functional vitamin K epoxide reductase (VKOR), wherein the recombinant nucleic acid coding for the VKOR comprises a nucleotide sequence selected from the group consisting of:

1) a nucleotide sequence that encodes an amino acid sequence having at least 80% identity with the amino acid sequence of SEQ ID NO:10 and that encodes a VKOR;

2) a nucleotide sequence that that encodes a human VKOR;

3) a nucleotide sequence that encodes a mouse VKOR;

4) a nucleotide sequence that encodes a rat VKOR;

5) a nucleotide sequence that encodes a zebrafish VKOR;

6) a nucleotide sequence that encodes a Xenopus VKOR; and

7) a nucleotide sequence that encodes an Anopheles VKOR, and a recombinant nucleic acid coding for a vitamin K dependent protein, wherein both the recombinant VKOR and the recombinant Vitamin K dependent protein are expressed in said cells.

10. The cell culture system of claim 9 , wherein the cultured cells are mammalian cells.

11. The cell culture system of claim 10 , wherein the mammalian cells are selected from the group consisting of one or more of the following: CHO cells and HEK293 cells.

12. The cell culture system of claim 9 , wherein the recombinant Vitamin K dependent protein is a coagulation factor.

13. The cell culture system of claim 12 , wherein the coagulation factor is selected from the group consisting of one or more of the following: factor II, factor VII, factor VIIa, factor IX, factor X, prothrombin, Protein C, activated Protein C and Protein S.

14. The cell culture system of claim 13 , wherein the coagulation factor comprises human factor IX.

15. A method of producing a vitamin K dependent protein in a host cell, comprising the steps of:

(a) providing the isolated host cell of claim 1 ; and

(b) expressing the recombinant nucleic acids of the host cell of step (a), thereby producing the vitamin K dependent protein in the host cell.

16. A method of producing a vitamin K dependent protein in a host cell, comprising the steps of:

(a) providing the isolated host cell of claim 1 , having a recombinant nucleic acid coding for a vitamin K dependent protein integrated into its genome; and

(b) expressing the nucleic acids of the host cell of step (a), thereby producing the vitamin K dependent protein in the host cell.

17. The method of claim 16 , wherein the recombinant nucleic acid coding for a vitamin K dependent protein is stably expressed.

18. A method of producing a vitamin K dependent protein in a host cell, comprising the steps of:

(a) providing the isolated host cell of claim 1 , having a recombinant nucleic acid coding for a vitamin K epoxide reductase (VKOR) integrated into its genome; and

(b) expressing the nucleic acids of the host cell of step (a), thereby producing the vitamin K dependent protein in the host cell.

19. The method of claim 18 , wherein the recombinant nucleic acid coding for VKOR is stably expressed.

20. A method of producing a vitamin K dependent protein in a cell culture system, comprising the steps of:

(a) providing the cell culture system of claim 19 ; and

(b) expressing the recombinant nucleic acids of the cells of the cell culture system of step (a), thereby producing the vitamin K dependent protein in the cell culture system.

21. A method of producing a vitamin K dependent protein in a cell culture system, comprising the steps of

(a) providing the cell culture system of claim 9 , having a recombinant nucleic acid coding for a vitamin K dependent protein integrated into the genome of the cells of the cell culture system; and

(b) expressing the nucleic acids of the cells of the cell culture system of step (a), thereby producing the vitamin K dependent protein in the cell culture system.

22. The method of claim 21 , wherein the recombinant nucleic acid coding for a vitamin K dependent protein is stably expressed.

23. A method of producing a vitamin K dependent protein in a cell culture system, comprising the steps of

(a) providing the cell culture system of claim 9 , having a recombinant nucleic acid coding for a vitamin K epoxide reductase (VKOR) integrated into the genome of the cells of the cell culture system; and

(b) expressing the nucleic acids of the cells of the cell culture system of step (a), thereby producing the vitamin K dependent protein in the cell culture system.

24. The method of claim 23 , wherein the recombinant nucleic acid coding for VKOR is stably expressed.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jan 14, 2010
From: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023782/0422 →
Continuity (4)
Continuation 11787072 · Apr 13, 2007
Continuation In Part PCTUS2005008643 · Mar 15, 2005
Continuation In Part 10573131 · Apr 18, 2006
Related Publication 20100255586A1 · Oct 7, 2010